887591-65-3 Usage
General Description
1-(tert-Butoxycarbonyl)-3-ethyl-3-piperidinecarboxylic acid, also known as Boc-ethyl-piperidinecarboxylic acid, is a chemical compound commonly used in organic synthesis. It is a derivative of piperidinecarboxylic acid, with the addition of a tert-butoxycarbonyl (Boc) protecting group on the nitrogen atom and an ethyl group on the carbon atom. The Boc protecting group is often used to prevent unwanted reactions at the nitrogen atom during chemical synthesis, while the ethyl group can provide additional functionality or reactivity to the molecule. 1-(tert-Butoxycarbonyl)-3-ethyl-3-piperidinecarboxylic acid is widely used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other complex organic molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 887591-65-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,5,9 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 887591-65:
(8*8)+(7*8)+(6*7)+(5*5)+(4*9)+(3*1)+(2*6)+(1*5)=243
243 % 10 = 3
So 887591-65-3 is a valid CAS Registry Number.
887591-65-3Relevant articles and documents
N-BENZYL-3-PHENYL-3-HETEROCYCLYL-PROPIONAMIDE COMPOUNDS AS TACHYKININ AND/ OR SEROTONIN REUPTAKE INHIBITORS
-
Page 44, (2010/02/06)
The present invention relates to heterocyclic derivatives of formula (1) wherein R1 represents a 5 or 6 membered heteroaryl group, in which the 5-membered heteroaryl group contains at least one heteroatom selected from oxygen, sulphur or nitrogen and the 6-membered heteroaryl group contains from 1 to 3 nitrogen atoms, or R1 represents a 4,5 or 6 membered heterocyclic group, wherein saids 5 or 6 membered heteroaryl or the 4,5 or 6 membered heterocyclic group may optionally be substituted by one to three substituents, which may be the same or different, selected from (CH2)pR6, wherein p is zero or an integer from 1 to 4 and wherein R and R2- R6 are each as defined in the description and pharmaceutically acceptable salts and solvates thereof; process for their preparation and their use in the treatment of conditions mediated by tachykinins and/or by selective inhibition of serotonin reuptake transporter protein.
